OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
Luc Magré, Monique M.A. Verstegen, Sonja I. Buschow, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006290-e006290
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 32

Landscape of human organoids: Ideal model in clinics and research
Xinxin Han, Chunhui Cai, Wei Deng, et al.
The Innovation (2024) Vol. 5, Iss. 3, pp. 100620-100620
Open Access | Times Cited: 21

Revolutionizing immune research with organoid-based co-culture and chip systems
Diana Papp, Tamás Korcsmáros, Isabelle Hautefort
Clinical & Experimental Immunology (2024)
Open Access | Times Cited: 12

Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1

Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy
Keyan Miao, Weici Liu, Jingtong Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20

Rebuilding the microenvironment of primary tumors in humans: a focus on stroma
Siwon Mun, Hyun Jin Lee, Pilnam Kim
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 3, pp. 527-548
Open Access | Times Cited: 10

Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Dongxi Xiang, Aina He, Rong Zhou, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3300-3316
Open Access | Times Cited: 10

Circular RNA as a source of neoantigens for cancer vaccines
Yi Ren, Thamizhanban Manoharan, Beijia Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008402-e008402
Open Access | Times Cited: 7

The utilisation of biliary organoids for biomedical applications
Zhongwen Lei, Yijun Yang, Yang Xiang
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access

Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives
Niclas Skarne, Rochelle C. J. D’Souza, Helen M. Palethorpe, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access

Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications
Colin D. Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access

Clinical applications of human organoids
Monique M.A. Verstegen, Robert P. Coppes, Anne Béghin, et al.
Nature Medicine (2025)
Closed Access

Organoid, organ-on-a-chip and traditional Chinese medicine
Jiayue Yang, Yu Jiang, Mingxing Li, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access

Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
Yushan Dong, Jingyu Chen, Yuhan Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115513-115513
Open Access | Times Cited: 16

Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 16

Tumor Organoids: The Era of Personalized Medicine
Natalia V Rassomakhina, A. Yu. Ryazanova, Astemir R. Likhov, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. S1, pp. S127-S147
Closed Access | Times Cited: 3

Current Applications of Colorectal Cancer Organoids: A Review
Quan-Yao Ban, Huashan Li, Xue-Xue Jiang, et al.
Journal of Gastrointestinal and Liver Diseases (2024) Vol. 33, Iss. 2, pp. 269-277
Open Access | Times Cited: 3

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
Hélène Lê, Jules Deforges, Pasquale Cutolo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Organoid co‐culture models of the tumor microenvironment promote precision medicine
Zhaoru Gu, Quanyou Wu, Bingqing Shang, et al.
Cancer Innovation (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7

Preclinical Models of Neuroblastoma—Current Status and Perspectives
Ewa Krawczyk, Joanna Kitlińska
Cancers (2023) Vol. 15, Iss. 13, pp. 3314-3314
Open Access | Times Cited: 6

Non-Polio Enterovirus C Replicate in Both Airway and Intestine Organotypic Cultures
Giulia Moreni, Hetty van Eijk, Gerrit Koen, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1823-1823
Open Access | Times Cited: 6

Human Pangenomics: Promises and Challenges of a Distributed Genomic Reference
Paolo Abondio, Elisabetta Cilli, Donata Luiselli
Life (2023) Vol. 13, Iss. 6, pp. 1360-1360
Open Access | Times Cited: 5

In vitro and in vivo experimental models for cancer immunotherapy study
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100210-100210
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top